SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (4022)2/3/1998 9:39:00 PM
From: squetch  Read Replies (1) | Respond to of 9719
 
>>There was an interesting piece about deCode in the WSJ 4-8 months ago.<< It was in 7/10/97. Not a bad deal for $12 million in venture funding.

The WSJ article described Iceland's population as "isolated, inbred..." [insert joke here]



To: Pseudo Biologist who wrote (4022)2/4/1998 3:04:00 PM
From: Vector1  Respond to of 9719
 
<<you see the $200 mill deal between Roche and Iceland's deCode?>>
I remember the article. Interesting the asset is a largely homogeneous population. Maybe there are other countries that can sell the value of their genetic homogeneity.
V1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News